2m 2m 2m 2m 2m 2m 2m
Biocryst Pharm (BCRX)
NASDAQ
$8.14+$0.02 (+0.20%)
Price as of Sep 11, 2026 7:53 PM EDT- $2.1BMarket Cap
- 2.65%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
Biocryst Pharm (BCRX)
$8.14+$0.02 (+0.20%)
BCRX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $8.12 | ||
Change | -$0.17 (-2.05%) | ||
Open | $8.30 | ||
High | $8.40 | ||
Low | $8.11 | ||
Previous Close | $8.29 | ||
Volume | 3,591,564 | ||
30-Day Average Volume | 3,444,868 | ||
1-Week Change | -18.47% | ||
1-Month Change | -21.47% | ||
1-Year Change | 2.65% | ||
3-Year Change | 18.71% | ||
5-Year Change | -46.58% | ||
Fundamentals | |||
Shares Outstanding | 255.5M | ||
Total Assets | $557.9M | ||
Market Cap | $2.1B | ||
Enterprise Value | $2.3B | ||
Period: QTR TTM FY | |||
Revenue | $157.5M | ||
Net Income | $78.4M | ||
Free Cash Flow | $104.1M | ||
EBIT | $87.8M | ||
EBITDA | $87.8M | ||
Net Working Capital | $275.8M | ||
EPS | $0.30 | ||
Enterprise Value/EBITDA | 26 | ||
Enterprise Value/Revenue | 15 | ||
P/B | -5 | ||
P/E | 27 | ||
PEG | 0 | ||
Price/Free Cash Flow | 20 | ||
Price/Operating Cash Flow | 20 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue